newsfilter
← Latest News
GlobeNewswire·

Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan

MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...